N-(N-BOC-Piperidino)pyrazole-4-carboxaldehyde

Catalog No. :
ACZVEU745
CAS No. :
1076224-00-4
Molecular Formula :
C14H21N3O3
Molecular Weight :
279.34

IUPAC Name:tert-butyl 4-(4-formyl-1H-pyrazol-1-yl)piperidine-1-carboxylate

N-(N-BOC-Piperidino)pyrazole-4-carboxaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$248.00Login to see priceInquiryInquiry
250mg95%$315.00Login to see priceInquiryInquiry
1g95%$645.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(N-BOC-Piperidino)pyrazole-4-carboxaldehyde
IUPAC Nametert-butyl 4-(4-formyl-1H-pyrazol-1-yl)piperidine-1-carboxylate
MDL No.MFCD19687734
Molecular FormulaC14H21N3O3
Molecular Weight279.34
SMILESCC(C)(OC(N1CCC(N2C=C(C=O)C=N2)CC1)=O)C
InChI KeyDSBDTGZARKKWJQ-UHFFFAOYSA-N
SynonymN-(N-BOC-Piperidino)pyrazole-4-carboxaldehyde;tert-butyl 4-(4-formyl-1H-pyrazol-1-yl)-1-piperidinecarboxylate;1-Piperidinecarboxylic acid, 4-(4-formyl-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester;tert-butyl 4-(4-formyl-1H-pyrazol-1-yl)piperidine-1-carboxylate
CAS No.1076224-00-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACZVEU745 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZVEU745 route product structure diagram
    ACZVEU7451076224-00-4
Inquiry

2. ACZVEU745 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQBVY936 route compound structure diagram
    ACQBVY9361197230-88-8 In Stock
  4. Then
  5. ACZVEU745 route product structure diagram
    ACZVEU7451076224-00-4
Inquiry

Comments (0)